DJ Bristol Myers Squibb Co. Stock Outperforms Competitors On Strong Trading Day
This article was automatically generated by MarketWatch using technology from Automated Insights.
Shares of Bristol Myers Squibb Co. $(BMY)$ rose 3.67% to $57.88 Monday, on what proved to be an all-around mixed trading session for the stock market, with the Dow Jones Industrial Average rising 0.08% to 43,461.21 and the S&P 500 Index falling 0.50% to 5,983.25.
This was the stock's fifth consecutive day of gains.
Bristol Myers Squibb Co. closed 5.27% short of its 52-week high of $61.10, which the company achieved on January 27th.
The stock outperformed some of its competitors Monday, as Johnson & Johnson $(JNJ)$ rose 0.89% to $163.74, Pfizer Inc. $(PFE)$ rose 1.33% to $26.65, and Abbott Laboratories $(ABT)$ rose 0.02% to $134.95.
Trading volume (13.1 M) eclipsed its 50-day average volume of 11.2 M.
Data source: Dow Jones Market Data, FactSet. Data compiled February 24, 2025.
This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.
(END) Dow Jones Newswires
February 24, 2025 16:38 ET (21:38 GMT)
Copyright (c) 2025 Dow Jones & Company, Inc.
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。